|
ACLX
|
Arcellx, Inc.
|
US
|
NASDAQ
|
|
ALXO
|
ALX Oncology Holdings Inc.
|
US
|
NASDAQ
|
|
APRE
|
Aprea Therapeutics, Inc.
|
US
|
NASDAQ
|
|
APTO
|
Aptose Biosciences, Inc.
|
US
|
NASDAQ
|
|
ARAV
|
Aravive, Inc.
|
US
|
NASDAQ
|
|
ARGX
|
argenx SE
|
US
|
NASDAQ
|
|
ATNM
|
Actinium Pharmaceuticals, Inc.
|
US
|
AMEX
|
|
BEAM
|
Beam Therapeutics Inc.
|
US
|
NASDAQ
|
|
BLRX
|
BioLineRx Ltd.
|
US
|
NASDAQ
|
|
CGEM
|
Cullinan Management, Inc.
|
US
|
NASDAQ
|
|
CLLS
|
Cellectis S.A.
|
US
|
NASDAQ
|
|
CRDF
|
Cardiff Oncology, Inc.
|
US
|
NASDAQ
|
|
CTIC
|
Cell Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ERAS
|
Erasca, Inc
|
US
|
NASDAQ
|
|
FBIO
|
Fortress Biotech, Inc.
|
US
|
NASDAQ
|
|
GLYC
|
GlycoMimetics, Inc.
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
|
HCWB
|
HCW Biologics Inc.
|
US
|
NASDAQ
|
|
KRON
|
Kronos Bio, Inc.
|
US
|
NASDAQ
|
|
MBRX
|
Moleculin Biotech, Inc.
|
US
|
NASDAQ
|